Samedan Ltd Pharmaceutical Publishers


Advanced search

Publications European Pharmaceutical Contractor European Biopharmaceutical Review International Clinical Trials Pharmaceutical Manufacturing and Packing Sourcer Innovations in Pharmaceutical Technology Subscribe Online White Papers Samedan app Pharmaceutical Directory Industry Events Calendar News and Press Releases Employment Opportunities Advertising with us Contact Us

home > ict

PUBLICATIONS

International Clinical Trials

International Clinical Trials (ICT) is a specialist journal designed to provide global coverage of key topics pertinent to the clinical trials sector.

Published quarterly, and edited by Dr Graham Hughes, the journal offers a platform of communication and information-sharing for executive and strategic decision-makers, seeking out new trends and marketing opportunities, as well as putting a spotlight on the latest innovations coming to market. ICT is specifically designed to be of interest to those actively seeking to source services for improved efficiency in what is an increasingly competitive market.

For further information please contact:
Advertising Nick Matthews	Editorial Rupert Gilbey

Connect with us on Twitter: follow @IntClinTrials

Read our publications on the go in the Samedan app for iPhone and iPad. You can download issues for offline reading and our archives go as far back as 2008! Download for free on the App Store.

View the digital version of ICT

	Subscribe
	Current Issue
	Archives
	Media Info
	Our Clients

Featured in this issue

Regional Trials
Market Analysis: Russia

Federal Factors

Russia has been a rising star of clinical R&D for 20 years, but the slowdown in market growth and emerging competition might block further progress. Maria Bomer at Bomer Pharma Consultancy assesses the country's trial landscape and the mixed success of new regulation.

Regional Trials
Central Laboratories

Local Impact

Trials in Russia may have doubled in the last decade, but the costs and delays stemming from its import/export procedures can curb sponsor enthusiasm. Tomasz Anyszek and Michal Dysko of Synevo Central Labs suggest that locally-based central lab networks can help the country get back on track.

Trial Design
Feasibility Assessment

Probable Cause

Graham Wylie at the Medical Research Network takes aim at the flawed model of feasibility assessments, arguing for a more patient-centric approach that looks beyond inclusion and exclusion criteria, and harnesses the wealth of digital data to drive trial recruitment.

Edited by
Dr Graham Hughes
Consultant in
Pharmaceutical
Development

Published quarterly in
February, May,
August and November

Industry Events

6th Annual Global Drug Delivery & Formulation Summit

9-11 February 2015, Dusseldorf, Germany

All your Drug Delivery and Formulation questions answered. All your problems solved. All your challenges overcome.
More info >>

All events >>

News and Press Releases

Gerresheimer Focuses on Pharmaceutical Customers at Pharmapack 2015

Düsseldorf/Paris, January 9, 2015 – Gerresheimer is a recognized partner to the pharmaceutical industry supplying standard packaging solutions and patient-friendly drug delivery systems from cough medicine bottles to asthma inhalers.
More info >>

All releases >>

Air Transport Publications

White Papers

Investigator Portals: Facilitating and Streamlining Communication & Collaboration with Study Sites

ArisGlobal

ArisGlobal LLC Investigator site personnel are often frustrated with the lack of transparency and communication with their sponsors, leading to significant dissatisfaction and withdrawal from current and future studies. The adoption of investigator portals gives sponsors a platform that fosters collaboration and improves site management. Learn about five key areas of sponsor-investigator site interactions deserving of electronic communication and collaboration. Technology and design aspects are also covered.
More info >>

All white papers >>